Long-Term Follow-Up of a Donor versus No-Donor Comparison in Patients with Multiple Myeloma in First Relapse after Failing Autologous Transplantation.

Abstract

We report the long-term clinical outcomes of a retrospective multicenter study that enrolled 169 patients with multiple myeloma (MM) in first relapse after failing autologous stem cell transplantation (SCT). After HLA typing at relapse, 79 patients with a suitable donor, 72 (91%) of whom eventually underwent salvage allogeneic SCT (allo-SCT), were compared… (More)
DOI: 10.1016/j.bbmt.2017.10.014

Topics

Cite this paper

@article{Patriarca2018LongTermFO, title={Long-Term Follow-Up of a Donor versus No-Donor Comparison in Patients with Multiple Myeloma in First Relapse after Failing Autologous Transplantation.}, author={Francesca Patriarca and Benedetto Bruno and Hermann Einsele and Francesco Spina and Luisa Giaccone and Vittorio Montefusco and Miriam Isola and Chiara Nozzoli and Andrea Nozza and F. Morabito and Paolo Corradini and Renato Fanin}, journal={Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation}, year={2018}, volume={24 2}, pages={406-409} }